THYROCARE TECHNOLOGIES
|
THYROCARE TECHNOLOGIES Last 5 Year Financial Ratios History
[Consolidated]
Mar2023 | Mar2022 | Mar2021 | Mar2020 | Mar2019 | |
---|---|---|---|---|---|
Operational & Financial Ratios | |||||
Earnings Per Share (Rs) | 12.45 | 33.28 | 21.14 | 16.75 | 16.15 |
CEPS(Rs) | 19.47 | 39.70 | 27.13 | 22.67 | 20.98 |
DPS(Rs) | 18.00 | 15.00 | 25.00 | 5.00 | 20.00 |
Book NAV/Share(Rs) | 100.09 | 98.89 | 80.26 | 68.68 | 81.69 |
Tax Rate(%) | 27.35 | 22.65 | 25.79 | 37.18 | 38.48 |
Margin Ratios | |||||
Core EBITDA Margin(%) | 23.27 | 40.03 | 34.62 | 39.97 | 38.26 |
EBIT Margin(%) | 17.74 | 39.22 | 31.00 | 32.64 | 34.28 |
Pre Tax Margin(%) | 16.82 | 38.67 | 30.83 | 32.22 | 34.13 |
PAT Margin (%) | 12.22 | 29.91 | 22.88 | 20.24 | 20.99 |
Cash Profit Margin (%) | 19.57 | 35.66 | 29.00 | 27.59 | 27.49 |
Performance Ratios | |||||
ROA(%) | 7.65 | 25.38 | 22.43 | 18.73 | 17.93 |
ROE(%) | 12.23 | 37.18 | 28.75 | 22.13 | 19.41 |
ROCE(%) | 17.61 | 48.42 | 38.51 | 35.14 | 31.36 |
Asset Turnover(x) | 0.63 | 0.85 | 0.98 | 0.93 | 0.85 |
Sales/Fixed Asset(x) | 1.19 | 1.49 | 1.36 | 1.22 | 1.17 |
Working Capital/Sales(x) | 2.69 | 2.87 | 3.40 | 6.15 | 3.49 |
Efficiency Ratios | |||||
Fixed Capital/Sales(x) | 0.84 | 0.67 | 0.73 | 0.82 | 0.86 |
Receivable days | 61.79 | 42.73 | 22.50 | 11.96 | 9.83 |
Inventory Days | 18.09 | 14.84 | 16.23 | 16.26 | 15.91 |
Payable days | 45.30 | 44.68 | 52.19 | 45.78 | 23.28 |
Valuation Parameters | |||||
PER(x) | 34.52 | 23.25 | 42.72 | 29.58 | 32.85 |
PCE(x) | 22.07 | 19.49 | 33.28 | 21.86 | 25.28 |
Price/Book(x) | 4.29 | 7.82 | 11.25 | 7.22 | 6.49 |
Yield(%) | 4.19 | 1.94 | 2.77 | 1.01 | 3.77 |
EV/Net Sales(x) | 4.26 | 6.93 | 9.62 | 6.01 | 6.93 |
EV/Core EBITDA(x) | 17.15 | 15.39 | 25.90 | 14.48 | 17.00 |
EV/EBIT(x) | 24.04 | 17.66 | 31.03 | 18.41 | 20.22 |
EV/CE(x) | 2.69 | 4.81 | 8.81 | 5.57 | 5.95 |
M Cap / Sales | 4.32 | 6.95 | 9.65 | 6.03 | 6.95 |
Growth Ratio | |||||
Net Sales Growth(%) | -10.56 | 19.05 | 13.90 | 7.78 | 13.08 |
Core EBITDA Growth(%) | -50.58 | 44.25 | 1.91 | 9.71 | -2.14 |
EBIT Growth(%) | -59.55 | 50.60 | 8.18 | 2.63 | -5.14 |
PAT Growth(%) | -63.46 | 55.67 | 28.74 | 3.90 | -9.48 |
EPS Growth(%) | -62.60 | 57.45 | 26.18 | 3.74 | -7.17 |
Financial Stability Ratios | |||||
Total Debt/Equity(x) | - | - | - | 0.01 | 0.01 |
Current Ratio(x) | 2.30 | 1.95 | 2.53 | 1.86 | 6.61 |
Quick Ratio(x) | 2.11 | 1.84 | 2.28 | 1.61 | 5.73 |
Interest Cover(x) | 19.34 | 71.94 | 176.25 | 76.62 | 226.43 |
Total Debt/Mcap(x) | - | - | - | - | - |
Compare Financial Ratios of peers of THYROCARE TECHNOLOGIES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
THYROCARE TECHNOLOGIES | ₹3,316.2 Cr | 0.8% | 0.2% | 36.8% | Stock Analytics | |
APOLLO HOSPITALS ENTERPRISE | ₹83,885.4 Cr | -3.8% | -7.5% | 25.6% | Stock Analytics | |
MAX HEALTHCARE INSTITUTE | ₹78,724.9 Cr | -2.6% | -1.2% | 65.9% | Stock Analytics | |
GLOBAL HEALTH | ₹37,983.1 Cr | 0.9% | 2.2% | 165.7% | Stock Analytics | |
FORTIS HEALTHCARE | ₹33,305.0 Cr | -4.4% | 1.7% | 68.7% | Stock Analytics | |
NARAYANA HRUDAYALAYA | ₹25,784.2 Cr | -0.4% | -4.9% | 61.9% | Stock Analytics |
THYROCARE TECHNOLOGIES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
THYROCARE TECHNOLOGIES | 0.8% |
0.2% |
36.8% |
SENSEX | -1.6% |
-2.1% |
19% |
You may also like the below Video Courses